BEGIN:VCALENDAR
CALSCALE:GREGORIAN
VERSION:2.0
METHOD:PUBLISH
PRODID:explore_courses
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTEND;TZID=America/Los_Angeles:20170403T132000
LAST-MODIFIED:20160925T011650
UID:explore_coursesc669c60a-0b6d-4402-99bb-6650bf25e676
DTSTAMP:20160925T011650
LOCATION:ScienceTeachingLearningCntr115
DESCRIPTION:Explores the design and enablement of new medicines that were born from a convergence of concepts and techniques from chemistry and biology.  Topics include fundamental methods for biomolecule synthesis and engineering and application to hybrid chemical/biologic drugs, as well as modern approaches for target discovery and validation. Prerequisite:  One year of undergraduate organic chemistry, as well as familiarity with concepts in biochemistry and molecular biology.
STATUS:CONFIRMED
SEQUENCE:0
SUMMARY:CHEM227 LEC
DTSTART;TZID=America/Los_Angeles:20170403T123000
CREATED:20160925T011650
RRULE:FREQ=WEEKLY;INTERVAL=1;UNTIL=20170607T132000;BYDAY=MO,WE,FR
END:VEVENT
END:VCALENDAR